Suzuki, Shiori https://orcid.org/0000-0001-5762-850X
Katagiri, Ryoko https://orcid.org/0000-0002-4867-2450
Yamaji, Taiki
Sawada, Norie
Imatoh, Takuya
Ihira, Hikaru
Inoue, Manami https://orcid.org/0000-0003-1276-2398
Tsugane, Shoichiro https://orcid.org/0000-0003-4105-2774
Iwasaki, Motoki
,
Sawada, N.
Tsugane, S.
Iwasaki, M.
Inoue, M.
Yamaji, T.
Katagiri, R.
Miyamoto, Y.
Ihira, H.
Abe, S. K.
Tanaka, S.
Moriya, T.
Minamizono, T.
Shirai, Y.
Kuniyoshi, H.
Yoshimi, T.
Sonoda, H.
Tagami, T.
Ando, T.
Kimura, T.
Kokubo, Y.
Yamagishi, K.
Mizoue, T.
Nakamura, K.
Takachi, R.
Ishihara, J.
Iso, H.
Kitamura, T.
Saito, I.
Yasuda, N.
Mimura, M.
Sakata, K.
Noda, M.
Goto, A.
Yatsuya, H.
Funding for this research was provided by:
National Cancer Center Research and Development Fund
Japan Agency for Medical Research and Development (JP16ck0106095, JP19ck0106266)
Article History
Received: 20 August 2021
Revised: 10 January 2022
Accepted: 21 January 2022
First Online: 10 February 2022
Ethics approval and consent to participate
: All precedures complied with the Helsinki Declaration. The comprehensive study protocol, including this study, was approved by the Institutional Review Board of the National Cancer Center, Tokyo, Japan (Approval No.2011-044). Before initiating this study, all living participants who had provided blood were contacted by mail and given the opportunity to opt-out of participation. Additionally, information on the study was posted on the website of our center to provide participants with the opportunity to opt-out at any time. Respondents who refused to participate were excluded from this study and their withdrawal of consent was documented.
: This manuscript does not contain any individual person’s data in any form, thus, consent for publication was not required.
: The authors declare no competing interests.